Search Results

Your search matched 57 results

  • 1
  • 2
#1

P2P Networks Huge for COVID-19 Patients, Responders | Blog

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#2

First COVID-19 Treatment Approved by FDA | Blog

The Food and Drug Administration (FDA) has approved the use of Veklury (remdesivir) for use in adult and adolescent patients 12 years of age and older for the treatment of COVID-19 in instances that require hospitalization.

#3

COVID’s Consequences Clearer as Cancer Cases Climb | Blog

At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.

#4

The Syneos Health Podcast, Coronavirus Special Edition: COVID-19 and Children | Perspectives

Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.

#5

The Syneos Health Podcast, Coronavirus Special Edition: Payers and COVID-19 | Perspectives

In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.

#6

Healthcare More Streamlined, Consumerized Post COVID-19 | Blog

Though once overwhelmed by the pandemic, many healthcare systems have already restructured themselves after learning critical lessons from COVID-19.

#7

COVID-19: Optimizing Promotions with HCP Preferences | Perspectives

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#8

Novo Nordisk Tailors Launch for COVID-era Customers | Blog

So, amid the pandemic, Novo Nordisk adjusted their launch to provide support customized for the time of COVID.

#9

The Syneos Health Podcast, Coronavirus Special Edition: Telemedicine in the Age of COVID-19 | Perspectives

In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.

#10

COVID-19 Kicks Drug Pricing Down the Road | In The Media

Meg Alexander, head of the reputation and risk management practice at Syneos Health, and Jeff Stewart, managing director at Syneos Health Consulting, teamed up with MM&M to discuss implications of COVID-19 and the upcoming US election on drug pricing.

#11

What to Expect From Contact Tracing in Our Next Phase of COVID-19 | Blog

As testing ramps up, contact tracers are working hard to alert citizens of their risk of exposure to COVID-19.

#12

Why Hospitals Really Like the Changes They Made for COVID-19 | Blog

Sinai Hospital, one of the oldest in the country, knew it needed large-scale innovation to accommodate and care for the influx of patients with COVID-19.

#13

As Moods Shift Around COVID, Pharma Makes New Social Plans | Blog

As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.

#14

COVID-19: How are Payers Managing These Days? | Perspectives

How are payers responding to COVID-19?

#15

Israel Gets Head Start in Race for COVID-19 Vaccine | Blog

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#16

Telemedicine Use and Field Force Engagement in the COVID-19 Era and Beyond for Dermatologists | Perspectives

Syneos Health surveyed 55 dermatologists to help us track and understand the impact COVID-19 has had on their engagement with telemedicine platforms and field force teams.

#17

Peer To Peer Insights in the COVID-19 Era and Beyond | Perspectives

COVID-19 has introduced an era of unprecedented events to industries across the globe.

#18

COVID vaccine deemed essential to re-opening activities—But, no-thanks, it’s not for me! | Blog

With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.

#19

Impacts of Telemedicine on Patient Engagement During COVID-19 | Blog

Understanding the impact that telemedicine has had on HCP behaviors including prescribing in the changing COVID-19 landscape.

#20

Telemedicine Use and Field Force Engagement in the COVID-19 Era and Beyond | Perspectives

As we continue to navigate these unprecedented times, Syneos Health conducted two surveys during the months of March and May to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.

#21

Here are a Few Changes We Can Expect to See in Our World After COVID | Blog

COVID-19 has accelerated the rate at which we’re seeing change happening around us.

#22

Thriving in COVID-19 With Flexible Marketing Strategies | In The Media

Pharma sales is set to change forever.

#23

Pivot Past the Pandemic | Perspectives

Life sciences commercialization in the COVID-19 era and beyond

#24

The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives

The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.

#25

There’s a Looming Mental Health Crisis but Tech is Here to Help | Blog

The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.

#26

Biohaven Launch on Track in Spite of Everything | Blog

The FDA approved Biohaven Pharmaceuticals’ migraine therapy, Nurtec, last month, just before the COVID-19 pandemic sent people the world over into lockdown.

#27

Leading Through Uncertainty Amidst the Global Pandemic | Perspectives

COVID-19 has created uncertainty, unparalleled business disruptions and shaken up the global workforce.

#28

Payer Priorities in a Pandemic | In The Media

What are payers focused on during the COVID-19 pandemic?

#29

PHARMA TRENDS 2020—2025: Four Headwinds Driving Healthcare Transformation — and What We’re Doing | Blog

How COVID-19 and 3 other barriers will transform healthcare over the next few years.

#30

Clear, Consistent Healthcare Communication: Lessons from COVID-19 | Blog

Patients are often at risk when presented with mixed messages.

  • 1
  • 2